Dataset opportunity
Meridian Medical — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Meridian Medical, usable for Regulatory RAG and Compliance Copilots.
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Regulatory Information Management Market = $2.12B in 2024, CAGR 10.41%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
Medium
Accessibility
Partial
Legal
Mixed ownership — restricted
Buyer persona
RegTech & compliance-AI vendors
Meridian Medical holds a proprietary Regulatory Records Dataset in Text modality, containing business records, industrial data, and regulatory proofs from its contract manufacturing operations. This structured and unstructured data, including proprietary process and validation information, is highly suitable for training or fine-tuning a Regulatory RAG system to automate and enhance compliance activities, such as answering regulatory queries and generating submission documents.
The Global Regulatory Information Management market this data serves was valued at $2.12B in 2024 and is projected to grow at a CAGR of 10.41%. Despite access complexities due to its status as a subsidiary of Kimal PLC and strict ISO 13485 requirements, the dataset's value is significant. These hurdles make the data a rare asset, as the proprietary process and validation data is not easily replicated, offering a distinct competitive advantage to an AI buyer looking to build a specialized regulatory tool. ⚠ Diligence (valuable data, access to negotiate): Subsidiary of Kimal PLC; decision-making may be centralized at the group level.; Contract manufacturing model means some design IP belongs to clients, but process/validation data is proprietary.; Strict medical regulatory requirements (ISO 13485) may limit data portability without anonymization. · corporate: subsidiary of Kimal PLC.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Meridian Medical possesses detailed regulatory documentation, including Design History Files (DHF) with full traceability and validation data. This dataset is a prime asset for RegTech and compliance-AI vendors seeking to build advanced Regulatory RAG systems. In a global regulatory information market growing over 10% annually to exceed $2.12 billion, this data provides the ground truth needed to automate complex compliance and submission processes.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
proprietary domain data (open lowers rarity)
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/open (current)
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
High buyer demand is driven by the need to manage increasing regulatory complexity, with the market for these solutions growing at a 10.41% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility52
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility51
medium difficulty, subsidiary of Kimal PLC
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License32
ownership=mixed, licensing=restricted
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of Kimal PLC
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ review — The company is a contract manufacturer whose core business is producing medical devices for other companies, not selling data; however, the valuable regulatory and production data it holds is likely the intellectual property of its clients, making it an unsuitable target. Issues: The primary issue is data ownership; as a contract manufacturer, the design, production, and regulatory data for the devices they make almost certainly belongs ; The provided URL (meridian-medical.com) is for a UK-based contract manufacturer, but numerous other distinct entities operate globally under the 'Meridian Medic
- Deep Qualification80
✓ pass — Meridian Medical is a strong data holder candidate. As a contract manufacturer of medical devices, it generates significant proprietary regulatory and process data. However, data ownership is mixed with client IP, and licensing rights are unknown as legal documents were inaccessible, requiring direct negotiation.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
This evidence indicates the holder produces structured marketing collateral, such as brochures, which can provide valuable product context for AI models analyzing device specifications.
Industrial data
This signal points to the existence of time-series data from manufacturing operations, proving the holder captures rigorous process monitoring information from its cleanroom assembly.
Regulatory records
This is direct confirmation of the core dataset, proving the holder owns comprehensive regulatory records, including critical Design History Files (DHF) that are essential for training compliance AI.
business_records
This evidence confirms the holder manages and documents its complex supply chains, providing a rich source of records for auditing material sourcing and component traceability.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Meridian Medical Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Regulatory Information Management Market = $2.12B in 2024, CAGR 10.41% (source: BlueWeave Consulting). Investment score 47.5/100 (confidence 0.56). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Antaresindustries — Regulatory Records Dataset Opportunity
View opportunity →healthcareAuxomedical — Maintenance Logs Dataset Opportunity
View opportunity →healthcareMedres — Maintenance Logs Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- Data licensing, term by term4 min read
- Is Your Data Worth Money?3 min read
- What is a Dataset Worth?3 min read